The metabolic pool of adenine nucleotides in platelets can be labeled by incubating platelets for 1 h in vitro with [l'C]adenosine or [82P]orthophosphate. When these platelets are treated with thrombin, the adenine nucleotides released are not labeled. Because of this, Holmsen's suggestion of a metabolically inert pool of granule nucleotides has been generally accepted. We have found that upon incubation of labeled rabbit platelets for longer times (up to 6 h) in vitro, or upon reinjection and reharvesting at times up to 66 h, the releasable pool of adenine nucleotides becomes labeled. Because the rates of s2p and 1"C incorporation into this releasable pool are similar, it seems likely that these labels enter the granules as ATP. Equilibrium between the metabolic and granule pools is complete by 18 h.
tion in the megakaryocytes. The specific radioactivity of the adenine nucleotides in the releasable (granule) pool of these platelets is the same as the specific radioactivity in the nonreleasable (metabolic) pool. Since inorganic phosphate in platelets (and undoubtedly in the megakaryocytes) exchanges with inorganic phosphate in plasma, and since the radioactivity of the latter decreases rapidly, the adenine nucleotides in the two pools must exchange to maintain the same specific radioactivity.
Transfer of adenine nucleotides into storage granules may represent a general phenomenon because it has been observed in the chromaffin cells of the adrenal medulla also.
We have previously observed that, if rabbit platelets are labeled in vivo by injection of [32P]orthophosphate (s2Pl), platelet ATP and ADP contain s~p, and considerable amounts of the labeled adenine nucleotides are released from the platelets upon treatment with thrombin (13, 20, 25) . Since thrombin causes the selective extrusion (release) of the contents of the storage granules of platelets (1 !), the amine storage granules presumably contain some of the labeled nucleotides. This is in contrast to the results obtained with platelets labeled in vitro. A number of investigators (8) (9) (10) 12) have found that platelets incubated in vitro with s2Pt, [a'C]adenosine, or [~'C]adenine form labeled adenine nucleotides which are not released upon addition of collagen or thrombin. Holmsen et al. (10) showed that the labeled adenine nucleotides are in the cytoplasm, the mitochondria, and the membranes, and concluded that only these metabolic pool nucleotides become labeled during a 3-h incubation in vitro. They proposed that the releasable adenine nucleotide pool is metabolically inert. More recently, DaPrada and Pletscher (5) and Kotelba-Witkowska et al. (15) have obtained evidence that there may be some transfer or exchange of adenine nucleotides from the cytoplasm into the amine storage granules.
We have now examined in more detail whether adenine nucleotides or components thereof are exchanged between the granule (releasable) and extragranule (nonreleasable) compartments of rabbit platelets by use of 82P1 or [t4C]adenosine as in vitro labels and 82P1 as an in vivo label for the adenine nucleotides.
MATERIALS AND METHODS

Nonradioactive Compounds
The thrombin used was crude bovine thrombin (Parke, Davis & Co., Detroit, Mich.). p-Tosyl-L-arginine methyl ester (HC1) (TAMe) was obtained from Nutritional Biochemicals Corp., Cleveland, Ohio. Prostaglandin E~ (PGE0 was a gift from the Upjohn Company, Kalamazoo, Mich. Pyruvate kinase and phosphoenolpyruvate were obtained from Boehringer Mannheim GmbH, New York. Luciferin-luciferase was purchased from E.I. Dupont de Nemours & Co., Wilmington, Del.
Radioactive Compounds
Carrier-free s2p~ in 0.02 N HCI was obtained from New England Nuclear-Canada, Ltd, Montreal, P.Q. [8-1'C]adenosine ([~'C]adenosine), sp act ~50 mCi/ mmol, and Na25tCrO, in sterile isotonie saline, sp act ~ 160 9249 Cr, were obtained from Amersham/Searle Corporation, Arlington Heights, II1.
Platelet Suspensions
Suspensions of washed platelets from rabbits were prepared in Tyrode's solution containing albumin (0.35%), after the method described by Ardlie et al. (I) .
Labeling of Platelets with Radioactive Cornpounds
IN VITgO
[ty Platelet adenine nucleotides were labeled by incubating the platelets suspended in Tyrode's-albumin solution with ["C]adr (10 9 10 L~ platelets) for 60 min at 37~ After the incubation period the platelets were resuspended in fresh Tyrode'salbumin solution unless stated otherwise.
s2el: Platelets were labeied with [3W] orthophosphate (0.5 mCi/10 t~ platelets) in Tyrode's-albumin solution from which unlabeled phosphate had been omitted. N-hydroxyethyl pipr sulfonic acid (HEPES buffer) (5 mM) was inciuded in the suspending medium to keep the pH at 7.35 during the incubation with s2P I for 60 min at 37~ After the incubation period the platelets were washed once in modified Tyrode'salbumin solution containing no calcium and resuspended in Tyrode's-albumin solution. (Platelet count: 1.0-1.5 • 10 e tzl).
DOUBLE LABELING: When platelets were labeled with both 5tCr and [t'C]adenosine, Na~5~CrO, (100 pCi/10 t~ platelets) was added to the first washing fluid. Platelets were incubated for 30 min at room temperature, resuspr in Tyrode's-albumm solution, incubated with [t'C]adenosine, and resuspended as described above.
IN VIvo
Platelets were labeled in vivo by intravenous injection into rabbits of 2 mCi [s~P]orthophosphate/kg, 1 mCi at 56 h and 1 mCi at 60 h before the collection of blood. Platelet suspensions were prepared as described. The final platelet count was adjusted to 1.0 1.5 • 10e/#l.
Platelet Release Reaction
1 ml of platelet suspension ( 1.0 x 10 y platelets//zl) was warmed at 37~ for 5 min and then incubated with the control solution (0.1 ml Tyrode's) or with the thrombin solution (0.1 tal) for 3 min at 37"C in a shaking device. The suspension was transferred rapidly to an Eppendorf centrifuge tube and centrifuged for 1 min at 12,000 g in an Eppendorf Microcentrifuge 3200 (Brinkmann Instruments, Rexdale, Ont.). The supernate was stored in an ice bath and analyzed for adenine nucleotides, lactate dehydrogenase activity, and radioactivity.
Repeated Thrombin Treatment
Platelets were treated three times with thrombin (0.05 U/ml) and recovered as single platelets after each treatment, as dascribed elsewhere (20) .
Assays of Radioactivity
The amount of radioactivity !n platelet suspensions (for total radioactivity) or in the supernate after centrifugation was determined as described previously (13) if a single label had been used. In experiments in which platelets were labeled with ~lCr and "C, 0.1 ml of the platelet suspension or the supernatant fluid was dissolved in 0.5 ml NCS solubilizer (Amersham/Searle Corp.) before 10 ml of the toluene-based scintillation fluid were added (5 g 2,5-diphenyloxazole and 0.3 g 2,2-1-phenylenebis- [5-phenyloxazole] in I liter of toluene). s~Cr and "C were measured simultaneously (21) in a Philips liquid scintiIlation counter. The sr of the 51Cr channel and the "C channel were such that 2.5% of the 61Cr was counted in the "C channel and 10% of the "C in the 5tCr channei. Counts were corrected for the spillover.
Adenosine Triphosphate Assay
For determination of the platelet ATP content, 10/~1 of 20% Triton X-100 in ethanol was added to 1.0 ml platelet suspension (1.0 x 10 y platelets/tzl). Platelet ATP and released ATP were assayed by the luciferin-luciferase assay (13, 26) .
~'C-labeled adenine nucleotides were separated by paper chromatography and counted by the methods described by Packham et al. (17) . 87 adenine nucleotides were separated from each other and from inorganic "P by low voltage paper electrophoresis for 16 h at 4~ with 0.12 M citrate buffer, pH 4.78.
Lactate Dehydrogenase
Lactate dehydrogenase (LDH) was assayed by the method of Bergmeyer et al. (4) .
Platelet Survival Studies
Platelets were labeled in vitro with ~~Cr, or ['P] orthophosphate as described above. Between 6 • 10' and 10 ~0 platelets in 2 3 ml Tyrode's-albumin solution were injected into each rabbit. The number of platelets injected corresponded to approximately 10-15% of the total number of platelets in the recipient rabbit. 1, 18, 42, 66, and 90 h after the injection of the labeled platelets, 6 ml of blood were withdrawn from an ear vein into I ml of the acid-citrate-dextrose solution of Aster and Jandl (2). Platelets were prepared from each sample, washed in calcium-free Tyrode's-albumin solution, and resuspended in 1 ml of calcium-free Tyrode's-albumin solution. Platelets were countr microscopicaUy, and the amount of radioactivity in 0.1 ml of the platelet suspension was measured. The spr radioactivity of the platelets (cpm/108 platelets) was calculated. In experiments in which platelets were labeled with 8~p~, aliquots were taken for electrophoretic sr of the "Plabeled adenine nucleotides. The results were expressed as counts per minute in ATP and PI per 10 ~ platelets. The biological half-lives of platelet radioactive labels were computed as described previously (19) .
RESULTS
Release of [32P]A TP from Washed Rabbit Platelets
IN VIVO LABELING" 32P 1 injected intravenously (1 mCi/kg) disappeared rapidly from the plasma. In an experiment in which the 32P1 was given as a single injection, 90% of it disappeared from the plasma between 4 min and 1 h after the injection. In experiments in which the rabbits were given two injections of 82p1 4 h apart, the amount of 32p in the platelets reached a maximum about 60-70 h after the first injection ( (Table I) . After stimulation with thrombin, these platelets released 32P-labeled nucleotides into the suspending fluid. The specific radioactivity of the released ATP was not significantly different from that of the platelets before thrombin treatment (Table II) . Means and SEM of nine experiments. Paired t test analysis. The suspensions contained between 30,000 and 35,000 cpm/ml suspension. The platelet count was 106/ 9 IN VITRO LABELING: The distribution of 3zp between ATP and ADP after in vitro incubation of platelets with 3zpl was very similar to that after in vivo labeling with 8zP l (Table I) . However, a much smaller percentage of the total a2p was found in the AMP of platelets labeled in vitro (Table I) .
In contrast to in vivo labeled platelets, washed rabbit platelets labeled with s2pl in vitro showed very little release of 32P-labeled ATP upon treatment with thrombin (0.5 U'/ml) (Table III) . Repeated treatment of these platelets with thrombin led to a large increase in the specific radioactivity of the [32P]ATP remaining within the platelets (Fig. 2) . This is in contrast to the much smaller increase in specific radioactivity in [3W]ATP found with the in vivo labeled platelets upon thrombin treatment (Fig. 2) .
One explanation for the difference between the in vitro and in vivo results with the 32P-labeled platelets could be that exchange of label between the cytoplasm and the granules does occur hut is so slow that it is not readily apparent in short-term in vitro studies. This possibility was examined in the following experiments.
Transfer of A den• Nucleotide
Components from the Nonreleasable TRANSFER  OF  PHOSPHATE:  TO  determine whether transfer or exchange of phosphate between the cytoplasmic and the granule adenine nucleotides of platelets occurs, platelets were incubated with ~2Pl in vitro, washed, and resuspended in fresh medium. They were then kept at 37~ and the percentage of labeled ATP that could be released upon stimulation with thrombin (0.5 U/ml) was determined at various times (Fig.  3 ). This figure shows that about 9% of the labeled ATP in the washed rabbit platelets was releasable 6 h after the addition of the 32P1 to the platelet suspension. The presence of labeled adenine nucleotides in the supernate of the thrombin-treated Specific radioactivities are expressed as a percentage of the specific radioactivity of the original platelet ATP (counts per minute per nanomoles ATP). Platelet radioactivity as "P at the beginning of the experiment was 34,732 cpm/ml of suspension when platelets had been labeled in vivo, and 1,030,000 cpm/ml of suspension when platelets had been labeled in vitro (10 y platelets/#l). platelet suspension could not be accounted for by platelet lysis. Less than 1% of the lactate dehydrogenase activity (LDH) of the total platelet suspension appeared in the supernate at the same time as the adenine nucleotides.
Compartment into the Releasable Compartment
To provide a longer time for equilibration of cytoplasmic and granule phosphate, an experiment was done in which rabbit platelets labeled with s2P 1 in vitro were infused into rabbits and harvested 18 h later. A suspension of washed platelets was prepared in the usual manner. When these platelets were treated with thrombin (0.05 U/ml) they released 46% of their labeled ATP in conjunction with 46% of their total ATP. Thus, the specific radioactivity of the released ATP (8,040 cpm/ nmol) was similar to that of the unstimulated platelets (8,120 cpm/nmol) (means of three observations). More than 90% of the radioactivity of the released adenine nucleotides was present as [s2P]ATP.
Since it was not possible to determine whether the "P was entering the releasable pool as phosphate or as adenine nucleotides, we examined whether the adenosine moiety would cross the amine storage organelle membrane as weil.
TRANSFER OF ADENOSINE: When washed rab- bit platelets were incubated with 4 #M [*'C]adennosine, it disappeared rapidly from the suspending medium. 1 h after the addition of the label to the platelet suspension, neariy 40% of the "C was recovered as ["C]ATP inside the platelets (Fig. 4  a) . When an aliquot of this platelet suspension was treated with thrombin (0.5 U/ml) 1 h after the addition of [l'C]adenosine to the platelet suspension, very little radioactivity was released as [t'C]ATP (Fig. 4 b) . Aliquots were treated with thrombin in this way at various times up to 5 h. In separate experiments it was found that a similar percentage of radioactive ATP was released by thrombin if platelets were isolated 18, 42, or 66 h after infusion of the labeled platelets into rabbits (Table IV) .
To ensure that the appearance of iabeled ATP in the supernatant fluid upon treatment with thrombin was not the result of platelet lysis rather than a specific release reaction, platelets were labeled in some experiments with both ["C]adenosine and 5~Cr before their injection into rabbits. ~'Cr was used as a platelet label so that it would be possible to detect platelet lysis (22) if it occurred when the reharvested platelets were treated with thrombin. Table IV shows that 18 h after the original labeling, about 50% of the labeled ATP was released upon thrombin treatment. However, very little s~Cr appeared in the supernate at the same time. Similar results were obtained if the platelets were reharvested 42 h after the infusion of the labeled platelets. However, the proportion of s~Cr lost from the platelets upon exposure to thrombin 42 h after the labeling was somewhat greater than that after 18 h.
Retention of [3=P]A TP and 87 in Platelets In Vivo
The following experiments were done to ascertain whether there is exchange between platelet phosphate and plasma phosphate, with corresponding changes in the specific radioactivity of ATP during the circulation of platelets in vivo. When the platelets were labeled in vitro with 9 or 51Cr and injected into rabbits, the total platelet 32p decreased more rapidly than the 51Cr associated with the platelets (Fig. 5) . However, the platelet "=Pl disappeared more rapidly than the platelet [s=P]ATP (Fig. 5) . The rate of disappearance of total platelet 9 in all forms was intermediate between these two rates. DISCUSSION Releasable, i.e. granule-bound, adenine nucleotides do not become labeled upon in vitro incubation of human platelets with s=P l, [l~C]adenosine, or ["C]adenine for a short period of time, although the nonreleasable metabolic adenine nucleotides become radioactive under the same conditions (10) . This has led to the conclusion that the granule pool does not readily incorporate adenine nucleotides from the metabolic pool. The adenine nucleotides in the granules have therefore been considered as a metabolically inert pool which can be released upon exposure of platelets to thrombin, collagen, or other release-inducing agents (10) . In rabbit platelets, however, DaPrada and Pletscher (5) were able to demonstrate a small but significant amount of newly formed [t'C]ATP in isolated amine storage granules upon exposure of intact platelets to ["C]adenosine for 2 h. The authors Experiment 1: platelets were isolated and incubated with ["C]adenosine. The platelets were resuspended in a fresh medium and injeeted into three rabbits. At 18, 42, and 66 h, orte of the rabbits was exsanguinated and the platelets were isolated, washed, and resuspended at a platelet count of 10y249 Samples of the platelet suspension were treated with thrombin (0.5 U/ml) for 3 min and then eentrifuged. The supernates were analyzed for released [t'C]ATP after chromatographic separation. Platelet suspensions after reharvesting: 18 h, 43,060 cpm/ml; 42 h, 8,360 cpm/ml; 66 h, 6,260 cpm/ml. Experiment 2: platelets were isolated and incubated with ["C]adenosine and Na~~~CrO,. The plateiets were resuspended in fresh media and injected into rabbits. Three experiments were done in which the platelets were harvested at 18 h and two in which the platelets were harvested at 42 h. At these times, suspensions of washed platelets were prepared and samples were treated with thrombin (0.5 U/ml) for 3 min and then centrifuged. The supernates were analyzed for 5~Cr and for released [~'C]ATP after chromatographic separation. (Mean values are shown.) Platelet radioactivity as ~'C at 18 h was between 25,310 and 90,700 cpm/ml of suspension; at 42 h it was between 10,600 and 15,470 cpm/ml suspension. Platelet radioactivity as ~xCr at 18 hr was between 13,050 and 56,560 cpm/ml of suspension; at 42 h it was between 8,080,and 19,250 cpm/ml of suspension.
concluded that some of the triphosphonucleotides formed in the metabolic pool could be transferred into the storage organelles. The results of the present experiments indicate that prolonged incubation in vitro of rabbit platelets that have been labeled in vitro with either 32P1 or [14C]adenosine results in the gradual appearance of labeled ATP that can be released from the platelets when they are exposed to thrombin. Similar observations were made when platelets were labeled with these substances in vitro, reinfused into rabbits and reharvested after a number of hours. There are two possible sources of this labeled nucleotide: the cytoplasm and the amine storage organelles. Released material could not have come from the cytoplasm because the percentages of 6~Cr or of lactate dehydrogenase activity which were lost from the cytoplasm were rauch less than the percentage of labeled ATP lost. In addition, shortly after labeling in vitro, when almost all of the label is in the metabolically active pool (10), addition of thrombin did not cause any release of labeled ATP. Thus, the storage granules must be the source of the radioactive ATP released from the platelets after prolonged incubation in vitro, or from platelets that had been reinjected and reharvested after 18-66 h.
Since both labels used in our study (32p and x~C) appeared in the releasable pool at a similar rate it seems likely that labeled ATP formed in the metabolic pool of the platelets was transferred as an intact molecule into the granule pool. It seems likely that ATP or its breakdown products can also be transferred from the granules to the cytoplasm since equilibration of the cytoplasmic and granule pool ATP appeared to be complete by 18 h; platelets harvested 18, 42, or 66 hours after the infusion into rabbits released practically the same percentage of radioactive ATP at all these times, upon addition of thrombin.
Further studies were done to investigate the transfer of labeled ATP or its products from the granules to the cytoplasm. After the injection of a2pj into rabbits, labeled inorganic phosphate is not incorporated rapidly into platelet adenine nucleotides because the labeling of the 01atelets is low when the plasma level of 32p is highest. Peak labeling of the platelets does not occur until 2-3 days after the injection of 82pj and appears to coincide with the known maturation time for rabbit platelets as derived from studies in which [3~S]sulfate (7) or [75Se]selenomethionine was used (6) . Thus, it appears reasonable to conclude that the majority of the 82p labeling of the platelets in the in vivo experiments occurred at some stage during the maturation of platelets in the megakaryocytes. Presumably, at some point during this process, both the cytoplasmic and granule nucleotides incorporate labeled phosphate by de novo synthesis. It seems likely that during the maturation of the platelets the specific radioactivity of the ATP in the cytoplasmic pool and the granule pool is the same. We found that the specific radioactivity of the ATP in . Labelr platelr wr162 injeeted into rabbits, and blood samplr were takr at the times indieatr Platelets werr isolatr and labelr compounds were separated and countr Speeific radioactivities (epm/10' platr162 arr plottr as a pr of the initial spr radioactivity of the correeponding J2P-labeled material. The halflife for the disappearanee of platelet-bound 5 ~Cr from the circula~ion was 24.9 • 2.0 h. both pools was also the same 60 h after injection of aaPt. If the ATP in the granule pool could not be transferred to the cytoplasm, one would expect that the specific radioactivity of the ATP in the two pools would differ at 60 h because the specific radioactivity of the plasma phosphate falls and there is an exchange of phosphate between platelets and plasma. (This is demonstrated by the fact that when 32P-labeled platelets were reinjected into rabbits, the specific radioactivity of platelet-bound 32p decreased more rapidly than that of plateletbound ~lCr, and by Holmsen's [81 demonstration that rabbit platelets in plasma take up 3~P-labeled inorganic phosphate,) However, 60 h after intravenous injection of s~p (at a time when the specific radioactivity of the plasma phosphorus was less than that of the platelet phosphorus), the ATP in the metabolic pool and the ATP in the releasable pool had the same specific radioactivity. 1 Therefore it seems likely that the ATP (or its metabolites) in the granules can be transferred to ~The small increase in the specific radioactivity after repeated thrombin-induced release reactions nnay be due to sonne preferential lose of an older (lese labeled) platelet population. During repeated thrombin-induced aggregation, about 30% of the platelr arr lost compared to 10% loss in the control suspr (20) .
the cytoplasm. Thus, ATP appears to exchange in both directions across the granule membrane.
From the results of the present experiments the absolute amount of ATP transported per unit time from the metabolic pool into the releasable pool can be estimated. From Table II it can be calculated that the metabolic pool contains 2.2 nmol of ATP per 108 platelets; from Fig. 3 and Fig. 4 it is apparent that about 2% of the labeled adenine nucleotides in the metabolic pool are transferred into the granules per hour. Thus, the rate of transfer of ATP can be calculated to be approximately 44 pmol/10 s platelets/h. This may be compared to the maximum rate of serotonin transfer from the cytoplasm into the granules of 17.2 nmol/10 s platelets/h that was observed in experiments reported previously (18) . Since serotonin is transferred into the granules at a rate that is at least 300 times greater than the rate of transfer of ATP, it seems unlikely that transfer of serotonin into the granules is linked to ATP transport.
Cells other than platelets also possess granules which eontain adenine nucleotides (16) . Stevens et al. (23) demonstrated that radioactive adenosine is taken up by the isolated perfused ent adrenat gland, and that radioactive ATP accumulates in the adrenal chromaffin granules and can be released upon stimulation with carbachol. This may indicate that labeled nucleotides formed in the metabolic pool of these cells can be transferred into the chromaffin granules. Nucleotide transfer from the metabolic pool into the storage granules of cells may thus be a phenomenon which is not limited to platelets. There is other evidence for translocation of adenine nucleotides across membranes. Among the best known is the transport of adenine nucleotides across the mitochondrial membrane via a specialized carrier system (14) . Adenine nucleotides can also diffuse across artificial bimolecular lipid membranes, a process that is stimulated by divalent metal cations (24) . Furthermore, isolated chromaffin granules have recently been shown to take up small amounts of radioactive ATP (3).
